Tag: Erlotinib,In the News,NSCLC,Non-Small Cell Lung Cancer,biomarker,blood-based cancer test,cancer diagnostics,chemotherapy,liquid biopsy,lung cancer,molecular diagnostic,oncology,personalized medicine
-
Blood Test May Help Fight Lung Cancer | Biodesix
A new blood test could improve the use of a popular lung cancer drug called erlotinib by allowing doctors to select which patients will react positively to the drug.